Alexander E. Perl, MD, associate professor of medicine, University of Pennsylvania, discusses the impact of CAR T-cell therapy for patients with acute lymphoblastic leukemia (ALL).
eHealthcare Solutions (EHS) manages advertising on this website.
We use cookies to ensure that we give you the best experience on our website.
By continuing, you agree to the use of cookies as per the EHS Privacy PolicyOk